NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered peptides from HkRoids? Mail in a sample (US only) and let us test it.

Test my supply
+3 more ↓
60%
Finnrick rating
#442 of 500 ranked vendors
55 of 82 classifiable tests passed
methodology · Purity focus
Finnrick analysis

HkRoids shows its strongest purity-focused evidence in GHK-Cu, Retatrutide, Tirzepatide, and BPC-157, but the catalog remains uneven. CJC-1295 and KPV drag the profile down, while Tesamorelin and Ipamorelin mix rebounds with identity, purity, or fill shocks; evidence is recent and broad, but batch consistency is weak.

methodology →
vendor intelligence report
Vendor Intelligence Report: HkRoids

Corporate records and linked web properties point to China/Hong Kong operations, while UBO stays unresolved. The report also traces non-verifying lab documents, a hidden rep roster, checkout/payment gaps, and clone-site exposure.

35 pages5 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.08
89%
7
2
Retatrutide
$1.36
77%
17
3
Tirzepatide
$0.50
74%
13
4
DSIP
-
67%
3
5
Ipamorelin
$0.94
67%
6
6
BPC-157
$0.94
66%
12
7
PT-141
-
59%
3
8
Tesamorelin
$2.58
51%
9
9
MOTS-c
$0.79
36%
4
10
CJC-1295
$2.35
32%
5
11
KPV
$0.82
20%
4
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%25 Mar 2026: 68%25 Mar 2026: 68%25 Mar 2026: 69%15 Apr 2026: 69%21 Apr 2026: 68%21 Apr 2026: 68%26 Apr 2026: 62%28 Apr 2026: 56%8 May 2026: 56%13 May 2026: 56%27 May 2026: 56%27 May 2026: 56%27 May 2026: 57%31 May 2026: 52%1 Jun 2026: 55%1 Jun 2026: 59%1 Jun 2026: 58%1 Jun 2026: 59%1 Jun 2026: 59%1 Jun 2026: 59%1 Jun 2026: 59%1 Jun 2026: 59%1 Jun 2026: 60%26 Jun 2026: 60%9 Jul 2026: 60%14 Jul 2026: 59%14 Jul 2026: 58%20 Jul 2026: 59%20 Jul 2026: 59%20 Jul 2026: 59%20 Jul 2026: 59%20 Jul 2026: 59%20 Jul 2026: 59%23 Jul 2026: 59%26 Aug 2026: 59%7 Sep 2026: 59%24 Sep 2026: 59%24 Sep 2026: 59%14 Oct 2026: 59%14 Oct 2026: 59%15 Nov 2026: current 60%68%60%60%Mar 26Nov 26
Peptide testing

Ordered peptides from HkRoids? Mail in a sample (US only) and let us test it.

Test my supply
HkRoids test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
14 Oct 2026
Pass
BPC-157
lab nameView COA
14 Oct 2026
Pass
Tirzepatide
lab nameView COA
24 Sep 2026
Pass
Retatrutide
lab nameView COA
24 Sep 2026
Fail
BPC-157
lab nameView COA
7 Sep 2026
Pass
Retatrutide
lab nameView COA
26 Aug 2026
Pass
BPC-157
lab nameView COA
23 Jul 2026
Fail
BPC-157
lab nameView COA
20 Jul 2026
Pass
Tirzepatide
lab nameView COA
20 Jul 2026
Fail
KPV
lab nameView COA
20 Jul 2026
Pass
DSIP
lab nameView COA
1-10 of 83

About HkRoids test results from Finnrick

HkRoids is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 11 peptides and 83 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible HkRoids peptides in this dataset are BPC-157 (12 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 83 recent tests.

Corrections
No corrections.
Peptide testing

Ordered peptides from HkRoids? Mail in a sample (US only) and let us test it.

Test my supply